Satellite in vitro fertilization: the Oregon experience

Article Abstract:

Satellite centers may achieve rates of in vitro fertilization (IVF) similar to those of the main hospital. Satellite centers may make the IVF service available to couples who live an inconvenient distance from the main hospital. Researchers compared the IVF success rates of 54 patients at a satellite center with 222 patients at the main center. The pregnancy rate of the satellite center patients was 39%, compared to 23% of the patients at the main hospital. The difference was not considered significant, as the main hospital included more couples with male infertility problems and with women over age 40. The live birth rate was comparable with 33% for the satellite center patients and 21% for patients at the main hospital. IVF satellite centers may reduce costs.

Services, Ambulatory care facilities, Clinics, Fertilization in vitro, Human, Human fertilization in vitro, Patient monitoring, Physiologic monitoring

---

Gonadotropin-releasing hormone agonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells

Article Abstract:

Gonadotropin-releasing hormone (GnRH) antagonists used in conjunction with in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) may produce more mature eggs and better quality embryos than GnRH agonists do. Researchers studied the effects of the GnRH antagonist Nal-Glu on 15 out of 30 women having controlled ovarian hyperstimulation as part of IVF or GIFT. Women who received Nal-Glu during the late follicular phase of the menstrual cycle had more mature eggs and higher quality embryos. Nal-Glu kept the levels of estradiol and luteinizing hormone (LH) down. High levels of these two hormones are associated with poor quality eggs and early miscarriages. Nal-Glu did not cause side effects and was more convenient than the GnRH agonist.

Physiological aspects, Gonadotropin releasing hormone, Gonadorelin

---

Subcutaneous human menopausal gonadotropin administration for controlled ovarian hyperstimulation with intrauterine insemination cycles

Article Abstract:

Injecting human menopausal gonadotropin subcutaneously appears to be as effective as intramuscular injections in stimulating ovulation in women with infertility. This was the conclusion of a study of 50 women, half of whom injected subcutaneously and half intramuscularly.

Evaluation, Dosage and administration, Gonadotropin, Gonadotropins, Injections, Hypodermic, Subcutaneous injections

Similar abstracts:

• Abstracts: Effect of antenatal thyrotropin-releasing hormone on uterine contractility, blood pressure, and maternal heart rate
• Abstracts: Human immunodeficiency virus infection and women: a survey of missed opportunities for testing and diagnosis. Is the management of epidural analgesia associated with an increased risk of cesarean delivery?
• Abstracts: A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy
• Abstracts: Maternal birth weight in relation to plasma lipid concentrations in early pregnancy. Maternal birth weight and cesarean delivery in four race-ethnic groups
• Abstracts: The magnetic resonance imaging-based fetal-pelvic index: a pilot study in the community hospital. Preeclampsia into eclampsia: toward a new paradigm

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.